Distinct double-negative T-cell subpopulations correlate with the clinical presentation of Chagas disease, with effector memory cells predominating in Chagas cardiomyopathy and representing a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
DN T-cell memory profiles differ by Chagas cardiac status; hypothesis-generating for immune biomarkers, needs prospective validation.
infection. Here, studying the distribution, activation status, and cytokine expression of memory DN T-cell subpopulations in Chagas disease patients without cardiac involvement (indeterminate form-IND) or with Chagas cardiomyopathy (CARD), we report that while IND patients displayed a higher frequency of central memory, CARD had a high frequency of effector memory DN T cells. In addition, central memory DN T cells from IND displayed a balanced cytokine profile, characterized by the concomitant expression of IFN-γ and IL-10, which was not observed in effector memory DN T cells from CARD. Supporting potential clinical relevance, we found that the frequency of central memory DN T cells was associated with indicators of better ventricular function, while the frequency of effector memory DN T cells was not. Importantly, decreasing CD1d-mediated activation of DN T cells led to an increase in IL-10 expression by effector memory DN T cells from CARD, restoring a balanced profile similar to that observed in the protective central memory DN T cells. Targeting the activation of effector memory DN T cells may emerge as a strategy to control inflammation in Chagas cardiomyopathy and potentially in other inflammatory diseases where these cells play a key role.
No takes yet. Share an insight, caveat, or question.
Passos et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: